ChemPartner(SZ:300149) Sou Hu Cai Jing·2025-09-14 18:25Group 1 - The stock price of Ruizhi Pharmaceutical (300149) closed at 13.26 yuan on September 12, 2025, with an increase of 2.39% and a turnover rate of 6.02% [1] - On September 12, 2025, the net inflow of main funds was 20.86 million yuan, indicating increased short-term interest from major investors [2][4] - The company plans to issue shares to a specific investor, Ruilian Investment, at a price of 5.27 yuan per share, with a maximum issuance of 60,019,704 shares, aiming to raise up to 316.30 million yuan for working capital and bank loan repayment [2][4] Group 2 - The issuance will not change the company's control, with the actual controller remaining WOO SWEE LIAN, and after the issuance, Ruilian Investment will hold a 15.53% stake, becoming the controlling shareholder [2] - The application for the share issuance has been accepted by the Shenzhen Stock Exchange, and the updated documents were disclosed on the same day as the half-year report [2] - The issuance is subject to approval from the Shenzhen Stock Exchange and registration with the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2]